BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 223594)

  • 1. The hypocholesterolemic effect of terbufibrol and other drugs in normal and hypercholesterolemic baboons.
    Howard AN; Zschocke R; Löser R; Hofrichter G
    Atherosclerosis; 1979 Apr; 32(4):367-80. PubMed ID: 223594
    [No Abstract]   [Full Text] [Related]  

  • 2. On the mechanism of hypocholesterolemic effects of polyunsaturated lipids.
    Paul R; Ramesha CS; Ganguly J
    Adv Lipid Res; 1980; 17():155-71. PubMed ID: 6992526
    [No Abstract]   [Full Text] [Related]  

  • 3. Circulating lipoproteins in nonhuman primates.
    Rudel LL; Lofland HB
    Primates Med; 1976; 9():224-66. PubMed ID: 174071
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of KC-9432, a new hypolipidemic compound, on high density lipoprotein cholesterol in rats.
    Seri K; Sato R; Hamazaki Y; Yamamoto T; Ishiyama N
    Atherosclerosis; 1980 Sep; 37(1):97-102. PubMed ID: 6893550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary and drug treatment of primary hyperlipoproteinemia.
    Ann Intern Med; 1972 Aug; 77(2):267-94. PubMed ID: 4345081
    [No Abstract]   [Full Text] [Related]  

  • 6. Xanthomatosis and hyperlipoproteinemia; a review.
    Polano MK
    Dermatologica; 1974; 149(1):1-9. PubMed ID: 4372111
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of bran and cholestyramine on plasma lipids in monkeys.
    Malinow MR; McLaughlin P; Papworth L; Naito HK; Lewis LA
    Am J Clin Nutr; 1976 Aug; 29(8):905-11. PubMed ID: 821335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of hyperlipidemia.
    Levy RI; Morganroth J; Rifkind BM
    N Engl J Med; 1974 Jun; 290(23):1295-301. PubMed ID: 4363888
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of dietary polyunsaturated and saturated fats on lipoproteins in the baboon.
    Babiak J; Nichols AV; Gong EL; McMahan CA; Kuehl TJ; Mott GE; McGill HC
    Atherosclerosis; 1985 Oct; 57(1):1-17. PubMed ID: 4074459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum phospholipid alterations and their control by chlorophenoxyisobutyrate and betabenzalbutyrate in puromycin aminonucleoside induced nephrotic syndrome in the rat.
    Gallt C; Edwards KD; Paoletti R
    Life Sci II; 1970 May; 9(9):523-34. PubMed ID: 5452796
    [No Abstract]   [Full Text] [Related]  

  • 11. Lipid changes in the plasma lipoproteins of baboons given an atherogenic diet. 3. A comparison between lipid changes in the plasma of the baboon and chimpanzee given atherogenic diets and those in human plasma lipoproteins of type II hyperlipoproteinaemia.
    Howard AN; Blaton V; Vandamme D; Van Landschoot N; Peeters H
    Atherosclerosis; 1972; 16(2):257-72. PubMed ID: 4344001
    [No Abstract]   [Full Text] [Related]  

  • 12. Lipid and fatty acid modifications in plasma lipoproteins of baboons under atherogenic diet.
    Blaton V; Peeters H
    Acta Zool Pathol Antverp; 1969 May; 48():233-42. PubMed ID: 4357474
    [No Abstract]   [Full Text] [Related]  

  • 13. Laboratory models for atherosclerosis.
    Kritchevsky D
    Adv Drug Res; 1974; 9():41-53. PubMed ID: 4377198
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of combined clofibrate-cholestyramine treatment on serum and tissue cholesterol pools and on cholesterol synthesis in hypercholesterolemic swine.
    Kim DN; Lee KT; Reiner JM; Thomas WA
    Exp Mol Pathol; 1975 Aug; 23(1):83-95. PubMed ID: 1157892
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of diet and drug therapy on the level of high density lipoprotein cholesterol in patients with primary hyperlipoproteinemia].
    Padosh D; Kustosh D; Puchok I; Dem'ianova N; Audikovski M
    Klin Med (Mosk); 1981 Sep; 59(9):45-8. PubMed ID: 7311430
    [No Abstract]   [Full Text] [Related]  

  • 16. HDL-cholesterol: the negative risk factor for coronary heart disease.
    Tan MH
    Ann Acad Med Singap; 1980 Oct; 9(4):491-5. PubMed ID: 7018364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of spirulina on serum lipoproteins and its hypocholesterolemic activities].
    Chen LC; Chen JS; Tung TC
    Taiwan Yi Xue Hui Za Zhi; 1981 Sep; 80(9):934-42. PubMed ID: 6948087
    [No Abstract]   [Full Text] [Related]  

  • 18. The effects of low cholesterol, high polyunsaturated fat, and low fat diets on plasma lipid and lipoprotein cholesterol levels in normal and hypercholesterolemic subjects.
    Schaefer EJ; Levy RI; Ernst ND; Van Sant FD; Brewer HB
    Am J Clin Nutr; 1981 Sep; 34(9):1758-63. PubMed ID: 6945041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of heparin and clofibrate on blood-serum lipid levels in patients with ischaemic heart disease.
    Haviar V; Riecanský L; Kusá O; Luknárová O
    Cor Vasa; 1972; 14(3):188-96. PubMed ID: 4344417
    [No Abstract]   [Full Text] [Related]  

  • 20. [Lowering of the lipoproteins in type IIa hyperlipoproteinemia by means of bezafibrate. Comparison with clofibrate].
    Mertz DP; Suermann I; Loewer H
    MMW Munch Med Wochenschr; 1979 Oct; 121(40):1295-6. PubMed ID: 226879
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.